As of April 19, 2025, CervoMed (CRVO) has a market cap of $85.287 million USD. According to our data, CervoMed is ranked No.7704 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $85.29 M |
341.59%
|
Dec 31, 2024 | $19.31 M |
-69.33%
|
Dec 29, 2023 | $62.98 M |
0.53%
|
Dec 30, 2022 | $62.65 M |
-67.35%
|
Dec 31, 2021 | $0.19 B |
-61.25%
|
Dec 31, 2020 | $0.50 B |
73.91%
|
Dec 31, 2019 | $0.28 B |
-76.88%
|
Dec 31, 2018 | $1.23 B |
-88.76%
|
Dec 29, 2017 | $10.96 B |
-47.79%
|
Dec 30, 2016 | $20.99 B |
-77.40%
|
Dec 31, 2015 | $92.85 B |
-69.70%
|
Dec 31, 2014 | $306.42 B |
10.00%
|
Dec 31, 2013 | $278.56 B |
-84.21%
|
Dec 31, 2012 | $1.764 T |
-62.00%
|
Dec 30, 2011 | $4.643 T |
-21.88%
|
Dec 31, 2010 | $5.943 T |
-71.56%
|
Dec 31, 2009 | $20.892 T |
41.51%
|
Dec 31, 2008 | $14.764 T |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() AbbVie
ABBV
|
$306.02 B |
0.008 M
|
![]() USA
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.66 B |
0.000 M
|
![]() Israel
|
![]() Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
![]() USA
|
Market Cap | = | CRVO Stock Price | * | CRVO Shares Outstanding |
= | $9.80 | * | 8.70 M | |
= | $85.29 M |